Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN11225767Phase 3Completed
Phase 3, randomised, double-blind trial in gastrointestinal bleeding comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Death from haemorrhage within 5 days of randomisation, All-cause mortality and 2 more. Started Jan 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN11225767.